Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$1.7B |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
$931M |
| 3 |
iShares Russell 2000 ETF
IWM
|
$606M |
| 4 |
VMW
VMware, Inc
VMW
|
$442M |
| 5 |
NVIDIA
NVDA
|
$427M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$662M |
| 2 |
Home Depot
HD
|
$354M |
| 3 |
Cigna
CI
|
$323M |
| 4 |
Valero Energy
VLO
|
$271M |
| 5 |
Amphenol
APH
|
$236M |
Sector Composition
| 1 | Technology | 18.98% |
| 2 | Healthcare | 15.64% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 10.37% |
| 5 | Industrials | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Pfizer
PFE
$139B
| $141M | 0.07% |
4,253,114
+2,639,318
| +164% | +$87.5M |
|
127
Leidos
LDOS
$22.8B
| $141M | 0.07% |
1,528,458
+214,694
| +16% | +$19.8M |
|
128
BILL Holdings
BILL
$4.77B
| $141M | 0.07% |
1,295,585
+1,276,615
| +6,730% | +$139M |
|
129
Digital Realty Trust
DLR
$55.1B
| $140M | 0.07% |
1,160,310
+1,093,108
| +1,627% | +$132M |
|
130
DaVita
DVA
$9.72B
| $139M | 0.07% |
1,465,799
+291,816
| +25% | +$27.6M |
|
131
AutoZone
AZO
$70.7B
| $138M | 0.07% |
54,421
+15,161
| +39% | +$38.5M |
|
132
Option Care Health
OPCH
$4.64B
| $138M | 0.07% |
4,252,397
-200,748
| -5% | -$6.49M |
|
133
Keurig Dr Pepper
KDP
$39.6B
| $137M | 0.07% |
4,350,453
+4,317,875
| +13,254% | +$136M |
|
134
argenx
ARGX
$45B
| $137M | 0.07% |
278,322
+72,429
| +35% | +$35.6M |
|
135
HealthEquity
HQY
$8.45B
| $136M | 0.07% |
1,866,649
+569,806
| +44% | +$41.6M |
|
136
Bio-Rad Laboratories Class A
BIO
$7.8B
| $135M | 0.07% |
376,619
+120,055
| +47% | +$43M |
|
137
Parker-Hannifin
PH
$95.3B
| $135M | 0.07% |
345,715
+175,518
| +103% | +$68.4M |
|
138
Alcoa
AA
$8.04B
| $132M | 0.07% |
4,556,313
+1,395,071
| +44% | +$40.5M |
|
139
HP
HPQ
$26.9B
| $132M | 0.07% |
5,133,312
-883,800
| -15% | -$22.7M |
|
140
Target
TGT
$42.1B
| $131M | 0.07% |
1,187,069
-817,464
| -41% | -$90.4M |
|
141
Sensata Technologies
ST
$4.69B
| $131M | 0.07% |
3,466,837
+385,977
| +13% | +$14.6M |
|
142
Lam Research
LRCX
$127B
| $131M | 0.07% |
2,089,820
+1,583,410
| +313% | +$99.2M |
|
143
Tesla
TSLA
$1.08T
| $131M | 0.07% |
523,087
+407,695
| +353% | +$102M |
|
144
Freeport-McMoran
FCX
$66.2B
| $131M | 0.07% |
3,508,665
-324,206
| -8% | -$12.1M |
|
145
A.O. Smith
AOS
$10.1B
| $130M | 0.07% |
1,967,154
+699,283
| +55% | +$46.2M |
|
146
Royal Caribbean
RCL
$97.5B
| $130M | 0.07% |
1,410,014
-92,718
| -6% | -$8.54M |
|
147
Tapestry
TPR
$21.8B
| $129M | 0.07% |
4,478,836
+3,623,592
| +424% | +$104M |
|
148
Janus Henderson
JHG
$7B
| $129M | 0.07% |
4,986,767
+2,369,077
| +91% | +$61.2M |
|
149
Xylem
XYL
$34.4B
| $128M | 0.06% |
1,407,883
-511,230
| -27% | -$46.5M |
|
150
American Tower
AMT
$90.5B
| $128M | 0.06% |
778,145
+536,263
| +222% | +$88.2M |
|